Talzenna .75 mg/1 (Talazoparib CAPSULE) .75 mg/1

Talzenna .75 mg capsules are a pharmaceutical product used in cancer treatment. This medication contains talazoparib, a PARP inhibitor, and is manufactured by Pfizer Laboratories.

Strength

.75 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0069-1751-30) / 30 CAPSULE in 1 BOTTLE

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna .75 mg capsules are primarily used in the treatment of certain types of cancer. Talazoparib, the active ingredient, is a PARP inhibitor that works by targeting specific enzymes involved in DNA repair. This medication is often prescribed for patients with specific genetic mutations, such as BRCA mutations, which are commonly associated with breast and ovarian cancers. The use of Talazoparib can help in slowing the growth of cancer cells and improving patient outcomes.

Side Effects

Common effects of Talzenna .75 mg capsules may include fatigue, nausea, and anemia. Some patients may also experience vomiting, decreased appetite, and hair loss. These effects can vary in severity and may not affect everyone who takes the medication. It is important to consult with a healthcare provider for personalized advice on managing these effects.

Precautions & Warnings

When handling Talzenna .75 mg capsules, it is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature and kept out of reach of children. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Avoid Interactions

Talzenna .75 mg capsules may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided while taking this medication, as it may increase the risk of side effects. Always consult with a healthcare provider for personalized advice on managing potential interactions.

Frequently Asked Questions

Talzenna .75 mg capsules are used in the treatment of certain types of cancer, particularly those associated with BRCA mutations.

Talzenna .75 mg capsules are taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, anemia, vomiting, decreased appetite, and hair loss.

It is generally advised to avoid alcohol while taking Talzenna .75 mg capsules, as it may increase the risk of side effects.

Store Talzenna .75 mg capsules at room temperature and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.